070473543	070473543	CD	B-NP	O
|	|	NNP	I-NP	O
RH	RH	NNP	I-NP	O
|	|	VBD	B-VP	O
61438117	61438117	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7535805	7535805	CD	B-NP	O
|	|	CC	I-NP	O
2/10/2005	2/10/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Cardiomyopathy	Cardiomyopathy	NNP	I-NP	O
,	,	,	O	O
LV	LV	NNP	B-NP	O
thrombus	thrombus	IN	B-PP	O
|	|	NNP	B-NP	B-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/8/2005	2/8/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/14/2005	2/14/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
RONERO	RONERO	NN	B-NP	O
,	,	,	O	O
MALCOLM	MALCOLM	NN	B-NP	O
581-39-64-7	581-39-64-7	CD	I-NP	O
Coston	Coston	NNP	I-NP	O
Room	Room	NNP	I-NP	O
:	:	:	O	O
Ro	Ro	NNP	B-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
11/28/05	11/28/05	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BEMER	BEMER	NNP	B-NP	O
,	,	,	O	O
ETHAN	ETHAN	NNP	B-NP	O
ANGEL	ANGEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NN	B-NP	O
0.25	0.25	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/16	4/16	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/10/05	4/10/05	CD	B-NP	O
by	by	IN	B-PP	O
VARGO	VARGO	NNP	B-NP	O
,	,	,	O	O
RASHAD	RASHAD	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
07631098	07631098	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/18/05	4/18/05	CD	B-NP	O
by	by	IN	B-PP	O
LAMOREE	LAMOREE	NN	B-NP	O
,	,	,	O	O
TONY	TONY	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LASIX	LASIX	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
GLIPIZIDE	GLIPIZIDE	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
COUMADIN	COUMADIN	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7.5	7.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
TOPROL	TOPROL	NNP	B-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/16	4/16	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	B-protein
Required	Require	VBN	B-VP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
approximate	approximate	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
:	:	:	O	I-protein
2	2	CD	B-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
100	100	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
LOVENOX	LOVENOX	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
60	60	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
Q12H	Q12H	NNP	I-NP	I-protein
LANTUS	LANTUS	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12	12	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ARANESP	ARANESP	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DARBEPOETIN	DARBEPOETIN	NNP	I-NP	O
ALFA	ALFA	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
300	300	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
Q2WEEKS	Q2WEEKS	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
ordering	order	VBG	B-VP	O
:	:	:	O	O
Oncology	Oncology	NNP	B-NP	O
-	-	HYPH	B-NP	O
Chemotherapy	Chemotherapy	NNP	I-NP	O
Induced	Induced	NNP	I-NP	O
Anemia	Anemia	NNP	I-NP	O
Last	Last	JJ	I-NP	O
known	know	VBN	I-NP	O
Hgb	Hgb	NN	I-NP	B-protein
level	level	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
order	order	NN	B-NP	O
:	:	:	O	O
12.0	12.0	CD	B-NP	O
g/dL	g/dL	NN	I-NP	O
on	on	IN	B-PP	O
4/18/05	4/18/05	CD	B-NP	O
at	at	IN	B-PP	O
CGH	CGH	NN	B-NP	O
Symptoms	Symptom	NNS	I-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
Diagnosis	Diagnosis	NN	B-NP	O
:	:	:	O	O
Anemia	Anemia	NN	B-NP	O
in	in	IN	B-PP	O
Neoplastic	Neoplastic	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
285.22	285.22	CD	I-NP	O
Treatment	Treatment	NN	I-NP	O
Cycle	Cycle	NN	I-NP	O
:	:	:	O	O
Maintenance	Maintenance	NNP	B-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Alfonso	Alfonso	NNP	I-NP	O
Fabiani	Fabiani	NNP	I-NP	O
full	full	JJ	B-ADJP	O
;	;	:	O	O
Dr.	Dr.	NNP	B-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
Pt	Pt	NN	B-NP	O
.	.	.	O	O

to	to	TO	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Clyde	Clyde	NNP	I-NP	O
Pillips	Pillips	NNP	I-NP	O
full	full	JJ	B-ADJP	O
until	until	IN	B-SBAR	O
3/23	3/23	CD	B-NP	O
Dr.	Dr.	NNP	I-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
earlier	early	JJR	B-NP	O
appt	appt	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ward	Ward	NNP	I-NP	O
Lofaro	Lofaro	NNP	I-NP	O
at	at	IN	B-PP	O
D	D	NNP	B-NP	O
Gofffant	Gofffant	NNP	I-NP	O
Blvd	Blvd	NNP	I-NP	O
,	,	,	O	O
Ont	Ont	NNP	B-NP	O
Ca	Ca	NNP	I-NP	O
,	,	,	O	O
Vermont	Vermont	NNP	B-NP	O
12864	12864	CD	I-NP	O
March	March	NNP	I-NP	O
,	,	,	O	O
12	12	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
1/13/05	1/13/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jim	Jim	NNP	I-NP	O
Panther	Panther	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
New	New	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
LV	LV	NNP	B-NP	O
thrombus	thrombus	IN	B-PP	O
PRINCIPAL	PRINCIPAL	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiomyopathy	Cardiomyopathy	NNP	I-NP	O
,	,	,	O	O
LV	LV	NNP	B-NP	O
thrombus	thrombus	IN	B-PP	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CMP	CMP	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Adenosine-MIBI	Adenosine-MIBI	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
71yoF	71yoF	NN	B-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
recurrent	recurrent	JJ	I-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
s/p	s/p	NN	I-NP	O
2	2	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
taxol	taxol	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
of	of	IN	B-PP	O
herceptin	herceptin	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
who	who	WP	B-NP	O
p/w	p/w	VBP	B-VP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
worsening	worsen	VBG	B-VP	O
fatigue	fatigue	NN	B-NP	O
and	and	CC	O	O
DOE	DOE	NNP	B-NP	O
found	find	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
new	new	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
15	15	CD	I-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
LV	LV	NN	I-NP	O
mural	mural	NN	I-NP	O
thrombus	thrombus	NN	I-NP	O
.	.	.	O	O

Fatigue	Fatigue	NNP	B-NP	O
began	begin	VBD	B-VP	O
around	around	RB	B-NP	O
a	a	DT	I-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
taxol	taxol	NN	B-NP	O
therapy	therapy	NN	I-NP	O
started	start	VBD	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
CP/PND/orthopnea	CP/PND/orthopnea	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
increasing	increase	VBG	B-VP	O
abd	abd	NN	B-NP	O
girth	girth	NN	I-NP	O
or	or	CC	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
denies	deny	VBZ	B-VP	O
URI	URI	NN	B-NP	O
sx	sx	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
n/v/d	n/v/d	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
f/c	f/c	NN	I-NP	O
.	.	.	O	O

Can	Can	MD	B-VP	O
walk	walk	VB	I-VP	O
barely	barely	RB	B-NP	O
one	one	CD	I-NP	O
flight	flight	NN	I-NP	O
before	before	IN	B-PP	O
DOE	DOE	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
claudication	claudication	NN	I-NP	O
sx	sx	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
sleep	sleep	NN	I-NP	O
on	on	IN	B-PP	O
side	side	NN	B-NP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
pillow	pillow	NN	I-NP	O
.	.	.	O	O

Noted	Note	VBN	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
and	and	CC	O	O
pleural	pleural	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	B-protein
8/22	8/22	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
brca	brca	NN	I-NP	I-protein
staging	stag	VBG	B-VP	I-protein
-RRB-	-RRB-	NN	B-NP	I-protein
,	,	,	O	O
subsequent	subsequent	JJ	B-NP	O
w/u	w/u	NN	I-NP	O
included	include	VBD	B-VP	O
echo	echo	RB	B-ADVP	O
at	at	IN	B-PP	O
Tulok	Tulok	NNP	B-NP	O
4/25	4/25	CD	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	JJ	B-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
I	I	NN	I-NP	O
+	+	SYM	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
to	to	TO	B-PP	O
r/o	r/o	NN	B-NP	O
mets	met	NNS	I-NP	O
,	,	,	O	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	I-NP	O
,	,	,	O	O
started	start	VBD	B-VP	O
heparin	heparin	NN	B-NP	O
drip	drip	NN	I-NP	O
with	with	IN	B-PP	O
bolus	bolus	NN	B-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
Brca	Brca	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
originally	originally	RB	B-ADVP	O
dx	dx	NN	B-NP	O
1986	1986	CD	I-NP	O
,	,	,	O	O
her2	her2	NN	B-NP	B-protein
positive	positive	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
fibroids	fibroid	NNS	I-NP	O
Meds	Med	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
:	:	:	O	O
lantus	lantus	NN	B-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
,	,	,	O	O
enalapril	enalapril	NN	B-NP	O
,	,	,	O	O
protonix	protonix	NN	B-NP	O
,	,	,	O	O
aranesp	aranesp	NN	B-NP	O
q2wk	q2wk	NN	I-NP	O
,	,	,	O	O
zometa	zometa	NN	B-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
T96	T96	NN	B-NP	O
.8	.8	NN	I-NP	O
,	,	,	O	O
hr99	hr99	NN	B-NP	B-protein
,	,	,	O	O
bp102/60	bp102/60	NN	B-NP	O
,	,	,	O	O
r20	r20	NN	B-NP	B-protein
,	,	,	O	O
sat	sit	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
3LNC	3LNC	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
aox3	aox3	NN	B-NP	O
,	,	,	O	O
nad	nad	NN	B-NP	O
,	,	,	O	O
H/N	H/N	NN	B-NP	O
:	:	:	O	O
jvp	jvp	NN	B-NP	O
10cm	10cm	NN	I-NP	O
water	water	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
thyroid	thyroid	JJ	I-NP	O
masses	mass	NNS	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
few	few	JJ	I-NP	O
bibasilar	bibasilar	JJ	I-NP	O
rales	rale	NNS	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
RRR	RRR	NN	I-NP	O
+	+	SYM	B-VP	O
s3	s3	NN	B-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
soft	soft	JJ	I-NP	O
ntnd	ntnd	NN	I-NP	O
nabs	nab	NNS	I-NP	O
,	,	,	O	O
ext	ext	JJ	B-NP	O
wwp	wwp	NN	I-NP	O
,	,	,	O	O
trace	trace	VBP	B-VP	O
pedal	pedal	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
:	:	:	O	O
Na	Na	NN	B-NP	B-protein
130	130	CD	I-NP	I-protein
,	,	,	O	O
K3	K3	NN	B-NP	B-cell_line
.5	.5	CD	I-NP	I-cell_line
,	,	,	O	O
gluc	gluc	NN	B-NP	B-protein
379	379	CD	I-NP	I-protein
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
1.95	1.95	CD	I-NP	O
with	with	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
pmn	pmn	NN	I-NP	O
,	,	,	O	O
hct	hct	NN	B-NP	O
36	36	CD	I-NP	O
,	,	,	O	O
plt	plt	NN	B-NP	B-protein
403	403	CD	I-NP	I-protein
,	,	,	O	O
inr	inr	NN	B-NP	O
1.2	1.2	CD	I-NP	O
,	,	,	O	O
ck/mb/tni	ck/mb/tni	NNS	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
at	at	IN	B-PP	O
96bpm	96bpm	NN	B-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
volts	volt	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
STTW	STTW	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Head	Head	JJ	B-NP	O
CT	CT	NN	I-NP	O
negative	negative	JJ	I-NP	O
;	;	:	O	O
CXR	CXR	NN	B-NP	B-protein
small	small	JJ	I-NP	O
left	left	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
.	.	.	O	O

**************	**************	SYM	O	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
******************	******************	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Heme	Heme	NNP	I-NP	O
:	:	:	O	O
L	L	NN	B-NP	O
ventricular	ventricular	JJ	I-NP	O
mural	mural	JJ	I-NP	O
apical	apical	JJ	I-NP	O
thrombus	thrombus	NN	I-NP	O
,	,	,	O	O
confirmed	confirm	VBN	B-VP	O
by	by	IN	B-PP	O
Echo	Echo	NNP	B-NP	O
BNGH	BNGH	NNP	I-NP	O
7/20/05	7/20/05	CD	I-NP	O
.	.	.	O	O

Head	Head	JJ	B-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
brain	brain	NN	B-NP	O
mets	met	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
gtt	gtt	NN	I-NP	O
,	,	,	O	O
goal	goal	NN	B-NP	O
PTT	PTT	NN	I-NP	O
60-80	60-80	CD	I-NP	O
sec	sec	NN	I-NP	O
,	,	,	O	O
bridging	bridge	VBG	B-VP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
starting	start	VBG	B-VP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
following	follow	VBG	B-PP	O
INR	INR	NN	B-NP	B-protein
for	for	IN	B-PP	O
goal	goal	NN	B-NP	O
2-3	2-3	NN	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
curr	curr	NN	I-NP	O
1.4	1.4	CD	I-NP	O
,	,	,	O	O
bridging	bridge	VBG	B-VP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
until	until	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
;	;	:	O	O
will	will	MD	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
New	New	NNP	B-NP	O
dilated	dilate	VBD	B-VP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
15	15	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
230	230	CD	I-NP	I-protein
.	.	.	O	O

CMP	CMP	NN	B-NP	B-protein
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
Herceptin	Herceptin	NN	B-NP	B-protein
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
actively	actively	RB	B-ADVP	O
ruling	rule	VBG	B-VP	O
out	out	RP	B-PRT	O
other	other	JJ	B-NP	O
possible	possible	JJ	I-NP	O
causes	cause	NNS	I-NP	O
,	,	,	O	O
esp	esp	NN	B-NP	O
ischemic	ischemic	JJ	B-ADJP	O
.	.	.	O	O

Adenosine-MIBI	Adenosine-MIBI	NN	B-NP	O
6/8/05	6/8/05	CD	I-NP	O
converted	convert	VBD	B-VP	O
to	to	TO	I-VP	O
planar	planar	VB	I-VP	O
imaging	imaging	NN	B-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
claustrophobia/movement	claustrophobia/movement	NN	I-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
sens/spec	sens/spec	NN	B-NP	O
c/w	c/w	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
concerning	concerning	NN	I-NP	O
perfusion	perfusion	NN	I-NP	O
defects	defect	NNS	I-NP	O
on	on	IN	B-PP	O
wet	wet	JJ	B-NP	O
read	read	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
official	official	JJ	B-NP	O
read	read	NN	I-NP	O
was	be	VBD	B-VP	O
`	`	``	O	O
non-diagnostic	non-diagnostic	JJ	B-ADJP	O
.	.	.	O	O
'	'	''	O	O

Consider	Consider	VB	B-VP	O
Cath	Cath	NN	B-NP	O
or	or	CC	I-NP	O
PET	PET	NN	I-NP	B-protein
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

ACE	ACE	NN	B-NP	O
,	,	,	O	O
SPEP/UPEP	SPEP/UPEP	NN	B-NP	O
pending	pending	NN	I-NP	O
.	.	.	O	O

Fe	Fe	NN	B-NP	O
studies	study	NNS	I-NP	O
show	show	VBP	B-VP	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
rules	rule	VBZ	B-VP	O
out	out	RP	B-PRT	O
hemochromatosis	hemochromatosis	NN	B-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
at	at	IN	B-PP	O
0.333	0.333	CD	B-NP	O
,	,	,	O	O
?	?	.	O	O

hyperthyroidism	hyperthyroidism	NN	B-NP	O
;	;	:	O	O
T4	T4	NN	B-NP	O
wnl	wnl	NN	I-NP	O
,	,	,	O	O
THBR	THBR	NN	B-NP	B-protein
slightly	slightly	RB	B-NP	O
elev	elev	NN	I-NP	O
.	.	.	O	O

Slightly	Slightly	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
,	,	,	O	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
checking	check	VBG	B-VP	O
daily	daily	JJ	B-NP	O
I/O	I/O	NNP	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
goal	goal	NN	B-NP	O
is	be	VBZ	B-VP	O
neg	neg	NN	B-NP	O
0.5-1	0.5-1	CD	I-NP	O
L	L	NN	I-NP	O
daily	daily	JJ	I-NP	O
TBB	TBB	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
Enalapril	Enalapril	NNP	B-NP	O
,	,	,	O	O
low-dose	low-dose	JJ	B-NP	O
Lopressor	Lopressor	NNP	I-NP	O
,	,	,	O	O
Digoxin	Digoxin	NNP	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
WBC	WBC	NN	B-NP	B-DNA
1.9	1.9	CD	I-NP	I-DNA
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
polys	poly	VBZ	B-VP	O
16	16	CD	B-NP	O
%	%	NN	I-NP	O
`	`	``	O	O
ANC	ANC	NNP	B-NP	O
~	~	VBZ	B-VP	O
400	400	CD	B-NP	O
.	.	.	O	O

Neutropenic	Neutropenic	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
still	still	RB	B-ADVP	O
on	on	IN	B-PP	O
precautions	precaution	NNS	B-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
increasing	increase	VBG	B-VP	O
steadily	steadily	RB	B-ADVP	O
and	and	CC	O	O
ANC	ANC	NNP	B-NP	O
improving	improve	VBG	B-VP	O
.	.	.	O	O

CIS	CIS	NN	B-NP	B-protein
T	T	NN	I-NP	I-protein
>	>	SYM	B-NP	O
100.5	100.5	CD	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
Appreciate	Appreciate	NNP	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
consult	consult	VBD	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Cornelius	Cornelius	NNP	I-NP	O
Hemby	Hemby	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
JMC	JMC	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

Enfield	Enfield	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
avoiding	avoid	VBG	B-VP	O
cath	cath	NN	B-NP	B-protein
given	give	VBN	I-NP	I-protein
neutropenia	neutropenia	NN	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
on	on	IN	B-PP	O
Tuesday	Tuesday	NNP	B-NP	O
6/8/05	6/8/05	CD	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
was	be	VBD	B-VP	O
non-diagnostic	non-diagnostic	JJ	B-ADJP	O
.	.	.	O	O

Lopressor	Lopressor	NNP	B-NP	O
,	,	,	O	O
Enalapril	Enalapril	NNP	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endo	Endo	NNP	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HbA1c	HbA1c	NN	B-NP	O
8.2	8.2	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
12	12	CD	I-NP	O
mg	mg	NN	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
SC	SC	NNP	I-NP	O
QAC	QAC	NNP	I-NP	O
,	,	,	O	O
Glipizide	Glipizide	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	B-protein
0.3	0.3	CD	I-NP	I-protein
,	,	,	O	O
T4	T4	NN	B-NP	B-cell_line
7.7	7.7	CD	I-NP	I-cell_line
,	,	,	O	O
THBR	THBR	NN	B-NP	O
1.29	1.29	CD	I-NP	O
.	.	.	O	O

Holding	Holding	NNP	B-NP	O
Metformin	Metformin	NNP	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
Cr	Cr	NNP	B-NP	O
1.0	1.0	CD	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
DM	DM	NN	I-NP	O
and	and	CC	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
on	on	IN	B-PP	O
ACE	ACE	NN	B-NP	O
for	for	IN	B-PP	O
renal	renal	JJ	B-NP	O
protection	protection	NN	I-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Onc	Onc	NNP	I-NP	O
:	:	:	O	O
Per	Per	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
recommendations	recommendation	NNS	I-NP	O
,	,	,	O	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
hold	hold	VB	I-VP	O
Herceptin	Herceptin	NN	B-NP	B-protein
given	give	VBN	B-PP	O
current	current	JJ	B-NP	O
EF	EF	NN	I-NP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
PPx	PPx	NN	I-NP	O
:	:	:	O	O
Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Dispo	Dispo	NNP	I-NP	O
:	:	:	O	O
Follow-up	Follow-up	NNP	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Boris	Boris	NNP	I-NP	O
Heinis	Heinis	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RTCH	RTCH	NNP	I-NP	O
Cards	Cards	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Rashad	Rashad	NNP	I-NP	O
Brueske	Brueske	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LNH	LNH	NNP	I-NP	O
Onc	Onc	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Micheal	Micheal	NNP	I-NP	O
Petell	Petell	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PMH	PMH	NN	I-NP	O
PCP	PCP	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
LV	LV	NN	B-NP	O
thrombus	thrombus	NN	I-NP	O
and	and	CC	I-NP	O
prevention	prevention	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Lacy	Lacy	NNP	I-NP	O
Otterholt	Otterholt	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Ficto	Ficto	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
Systems	Systems	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Jeffrey	Jeffrey	NNP	I-NP	O
Ahluwalia	Ahluwalia	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AI	AI	NNP	I-NP	O
Onc	Onc	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Quincy	Quincy	NNP	I-NP	O
Wankel	Wankel	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
I	I	CD	I-NP	O
PCP	PCP	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Note	Note	VB	B-VP	O
to	to	TO	B-PP	O
PCP	PCP	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
needs	need	VBZ	B-VP	O
close	close	JJ	B-NP	O
INR	INR	NN	I-NP	O
f/u	f/u	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
immediate	immediate	JJ	I-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
lives	life	NNS	I-NP	O
in	in	IN	B-PP	O
Ston	Ston	NNP	B-NP	O
Ny	Ny	NNP	I-NP	O
Burb	Burb	NNP	I-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
Ter	Ter	NNP	I-NP	O
Lab	Lab	NN	I-NP	B-protein
near	near	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

F/u	F/u	NN	B-NP	O
with	with	IN	B-PP	O
Onc	Onc	NN	B-NP	O
re	re	NN	I-NP	O
change	change	NN	I-NP	O
of	of	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	B-protein
regimen	regimen	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
holding	hold	VBG	B-VP	I-protein
Herceptin	Herceptin	NN	B-NP	I-protein
as	as	IN	B-PP	O
likely	likely	JJ	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
CMP	CMP	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MICHELLO	MICHELLO	NNP	B-NP	O
,	,	,	O	O
FERMIN	FERMIN	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RE23	RE23	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/28/05	11/28/05	CD	I-NP	O
@	@	SYM	B-NP	O
01	01	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

